137 related articles for article (PubMed ID: 7277182)
1. Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.
Goto S; Yoshitomi H; Miyamoto A; Inoue K; Nakano M
J Pharmacobiodyn; 1980 Dec; 3(12):667-76. PubMed ID: 7277182
[TBL] [Abstract][Full Text] [Related]
2. Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease.
Goto S; Yoshitomi H; Miyamoto A; Yamada H; Fujii S; Nakayama T; Fujiwara K
J Pharmacobiodyn; 1981 Nov; 4(11):865-73. PubMed ID: 7328487
[TBL] [Abstract][Full Text] [Related]
3. Renal actions of piretanide and three other "loop" diuretics.
McNabb WR; Noormohamed FH; Brooks BA; Lant AF
Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
[TBL] [Abstract][Full Text] [Related]
4. Loop-acting diuretics do not bind to Tamm-Horsfall urinary glycoprotein.
Brunisholz MC; Lynn KL; Hunt JS
Clin Sci (Lond); 1987 Sep; 73(3):305-10. PubMed ID: 3652635
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.
Berg KJ; Walstad RA; Bergh K
Br J Clin Pharmacol; 1983 Mar; 15(3):347-53. PubMed ID: 6342640
[TBL] [Abstract][Full Text] [Related]
6. Protein binding and bilirubin displacing properties of bumetanide and furosemide.
Turmen T; Thom P; Louridas AT; LeMorvan P; Aranda JV
J Clin Pharmacol; 1982; 22(11-12):551-6. PubMed ID: 7161408
[TBL] [Abstract][Full Text] [Related]
7. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia.
Takamura N; Maruyama T; Otagiri M
Clin Chem; 1997 Dec; 43(12):2274-80. PubMed ID: 9439444
[TBL] [Abstract][Full Text] [Related]
8. [Study of the binding of diuretics by serum proteins according to changes in tryptophan fluorescence].
Lebedev AA; Samokrutova OV
Farmakol Toksikol; 1989; 52(3):40-3. PubMed ID: 2792351
[TBL] [Abstract][Full Text] [Related]
9. Bumetanide binding to normal albumins and to albumin in renal failure.
Howlett MR; Auld WH; Murdoch WR; Skellern GG
Biopharm Drug Dispos; 1993 Aug; 14(6):503-10. PubMed ID: 8218968
[TBL] [Abstract][Full Text] [Related]
10. Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.
Marsh JD; Smith TW
Pharmacotherapy; 1984; 4(4):170-80. PubMed ID: 6384944
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the diuretic bumetanide in healthy subjects and patients with renal impairment.
Howlett MR; Skellern GG; Auld WH; Murdoch WR
Eur J Clin Pharmacol; 1990; 38(6):583-6. PubMed ID: 2373133
[TBL] [Abstract][Full Text] [Related]
12. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Clissold SP; Brogden RN
Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
[TBL] [Abstract][Full Text] [Related]
13. Albumin binding of bumetanide.
Robertson A; Karp W
Dev Pharmacol Ther; 1986; 9(4):241-8. PubMed ID: 3757731
[TBL] [Abstract][Full Text] [Related]
14. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the loop diuretic piretanide in renal failure.
Walter U; Röckel A; Lahn W; Heidland A; Heptner W
Eur J Clin Pharmacol; 1985; 29(3):337-43. PubMed ID: 4076330
[TBL] [Abstract][Full Text] [Related]
16. Protein binding characteristics of bumetanide.
Walker PC; Berry NS; Edwards DJ
Dev Pharmacol Ther; 1989; 12(1):13-8. PubMed ID: 2721330
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.
Marone C; Reubi FC; Lahn W
Eur J Clin Pharmacol; 1984; 26(4):413-8. PubMed ID: 6734705
[TBL] [Abstract][Full Text] [Related]
18. Disposition and response to bumetanide and furosemide.
Brater DC
Am J Cardiol; 1986 Jan; 57(2):20A-25A. PubMed ID: 3511654
[TBL] [Abstract][Full Text] [Related]
19. Alterations of furosemide binding to serum albumin induced by increased level of fatty acid.
Bojko B; Sułkowska A; Maciazek-Jurczyk M; Równicka J; Pentak D; Sułkowski WW
J Pharm Biomed Anal; 2010 Jan; 51(1):273-7. PubMed ID: 19709838
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
